Skip to content

Prediction of Renal Parenchymal Damage of CAKUT

Protocol for a Cohort Diagnostic Accuracy Study to Develop Prediction of Renal Parenchymal Damage and to Evaluate Accuracy of Renal Function in Congenital Anomalies of the Kidney and Urinary Tract (CAKUT)

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037535
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-12-01
Completion date
Unknown
Last updated
2020-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Anomalies of the Kidney and Urinary Tract (CAKUT)

Interventions

Gold Standard:DMSA scan: Intravenous injection of 99mTC-DMSA5mCi is followed by anterior and posterior planar imaging of the renal area 1 hour later. The DMSA scan images are read by 2 trained radiolo
diagnosis&#32
of&#32
damage&#32
includes&#32
MRI-DWI&#32
and&#32
the&#32
biomarkers&#32

Sponsors

Children's Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Patient that was diagnosed clinically and genetically as: 1. Renal parenchymal aplasia or ectopia, including simple renal aplasia,Multicystic Dysplastic Kidney, kidney tubules dysplasia, and hereditary cystic kidney: (1) disease renal agenesis (RA): With ultrasound diagnosis of unilateral renal absence; (2) Renal hypoplasia (RH)/renal dysplasia (RD) is usually defined as renal volume less than two standard deviations of the average of the same age, or renal total volume less than 50% of the normal value of the same age. RD refers to the presence of undifferentiated or not metaplastic tissue in the kidney, with or without renal volume reduction. Diagnosis is based on the ultrasonic findings of multicystic dysplastic kidney (MCDK) and the diagnosis of unilateral or bilateral renal functional defects by means of isotopic renal functional imaging (DMSA or DTPA); 2. Kidney tubular dysplasia: (1) the diagnosis of polycystic kidney disease(ADPKD/ARPKD) is mainly dependent on imaging; Patients with a family history of ADPKD can be diagnosed with more than 3 renal cysts on either side. those who with bilateral renal diffuse enlargement with multiple cysts should be clinically considered with PKD even without family history of ADPKD, and relevant gene screening is recommended; (2) Simple renal cyst: single renal cyst was found by ultrasound or other imaging examination; (3) Nephronophthisis, NPHP: ultrasonography showed enhanced renal echo or unclear boundary between cortex and medulla, with or without genetic diagnosis or involvement of other system, gene sequence should be considered. Genetic molecular diagnosis is the main diagnostic basis of NPHP diagnosis; (4) nephrocalcinosis and urinary calculi: the diagnosis depends on the ultrasound diagnosis and the examinations of serum and urine electrolyte and metabolite should be performed to further diagnose the primary disease; 3. Abnormalities of Ureter renal pelvis and/or bladder: (1) Dual collection system: Reduplication of kidney or renal pelvis/ureter depends on ultrasound, magnetic resonance imaging (MRI) diagnosis; (2) Urinary obstruction: Including ureteropelvic junction obstruction, ureterovesical junction obstruction or insufficiency. The diagnosis of obstruction depends on magnetic resonance urography (MRU) and isotopic dynamic renal imaging(DTPA); (3) vesicoureteral reflux: The diagnosis depends on voiding cysternography (VCUG); 4. Urinary tract anomalies: (1) Urethral absence/urethra atresia/ectopic orifice: Diagnosis depends on physical examination and VCUG examination; (2) Posterior urethral valve: Severe hydronephrosis can be found by ultrasound, and the diagnosis depends on VCUG examination.

Exclusion criteria

Exclusion criteria: 1. Patient with renal failure due to different causes but without urine specimen; 2. Other conditions that the researcher considers not suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
MRI-DWI images;urinary polypeptide;dimercaptosuccinic acid (DMSA) scan images;

Secondary

MeasureTime frame
disease gene;

Countries

China

Contacts

Public ContactJia Rao

Children's Hospital of Fudan University

jiarao@fudan.edu.cn+86 021-64932881

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026